WHO ICTRP trial
Effect and mechanism of cangma Pill on airway mucus hypersecretion in patients…
ITMCTR2200005895 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Recruiting
Key facts
| Trial ID | ITMCTR2200005895 |
|---|---|
| Public title | Effect and mechanism of cangma Pill on airway mucus hypersecretion in patients with stable bronchiectasis based on NE / EGFR / MUC5AC pathway |
| Scientific title | Effect and mechanism of cangma Pill on airway mucus hypersecretion in patients with stable bronchiectasis based on NE / EGFR / MUC5AC pathway |
| Primary sponsor | Beijing Hospital of Traditional Chinese Medicine, Capital Medical University |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | china |
| Conditions | Respiratory infectious diseases |
| Interventions | Intervention group:cangma pill;control group:Carbocysteine |
| Registration date | Apr 22, 2022 |
| Target size | Intervention group:30;control group:30 |
| Secondary IDs | ChiCTR2200058997;ChiMCTR2200005895 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: